Month: June 2024

Endeavour Mining plc (“the Company”) announces that on 25 June 2024 it received the following notification from Blackrock, Inc. of its interests in the Company as of 24 June 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BL6K5J42Issuer Name ENDEAVOUR MINING PLCUK or Non-UK Issuer UK2. Reason for Notification An acquisition or disposal of voting rights3. Details of person subject to the notification obligation Name BlackRock, Inc.City of registered office (if applicable) WilmingtonCountry of registered office (if applicable) USA4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above City of registered office (if applicable) Country of registered office (if applicable) 5. Date on which the threshold was crossed or reached...

ZIBO, China, June 25, 2024 (GLOBE NEWSWIRE) — Sunrise New Energy Co., Ltd. (“Sunrise New Energy”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced the acquisition of a significant new client, Times Geely (Sichuan) Power Battery Co., Ltd. (“Times Geely”), which will commence with a substantial monthly order of 300 tons of anode materials for power batteries. Times Geely is a joint venture between CATL(Contemporary Amperex Technology Co., Ltd.), the world’s largest power battery manufacturer and the global market share leader for seven consecutive years, and Zhejiang Geely Holding Group, a Fortune 500 auto manufacturer for eleven consecutive years. As a renowned manufacturer of electric vehicle batteries, Times Geely’s decision to place a new order underscores the high quality of Sunrise’s...

IRVINE, CA., June 25, 2024 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (NASDAQ: CETY), announced today that Vermont Renewable Gas, LLC (VRG), an affiliate of CETY in which CETY indirectly retains 49% ownership interest, has received a Permit to Construct and Operate from the Vermont Department of Environmental Conservation’s (Vermont DEC) Air Quality and Climate Division. Effective immediately, the permit allows VRG to construct and operate its proposed Vermont Renewable Gas – Lyndon (VRG – Lyndon) facility, a 2.2 MW biogas generation facility under development in Lyndonville, Vermont. Issued to VRG – Lyndon as a non-major source of air emissions, the Vermont DEC permit provides strict construction and operating guidelines specific to the biomass feedstock preparation, biogas production, and electric generation components...

First Commercial Agreement for DispersinB® WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB® technology. Biofilm is a known contributor to Meibomian gland dysfunction (MGD) and dry eye blepharitis syndrome (DEBS). The DispersinB® enzyme will be used to enhance I-MED’s line of eye care products. The license agreement covers a period of five years and includes minimum annual royalties, which will start in 2025. “This agreement is significant for Kane as it represents the first commercial agreement for DispersinB®,” said Marc Edwards, President & CEO. “We are delighted to partner with I-MED in providing DispersinB® biofilm...

CEOs of both companiesCEOs of both companiesTOKYO, Japan, June 25, 2024 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd. (Nasdaq: LRE) (“LRE” or “the Company”), a Japanese real estate developer of luxury residential properties including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, today announced that it has entered into a business alliance agreement with Samurai Capital Co., Ltd. an ESG-conscious real estate investment company also based in Tokyo. As per the agreement, which was signed on May 30, 2024, a trust beneficiary interest purchase agreement totaling approximately 4.1 billion Japanese yen, or about US$26.1 million, was concluded. About Lead Real Estate Co., Ltd Lead Real Estate Co., Ltd is a Japanese developer of luxury residential properties, including single-family homes...

SARASOTA, Fla., June 25, 2024 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has entered into a placement agency agreement for the purchase and sale of 1,100,000 shares of its common stock (or pre-funded warrants in lieu thereof) at an offering price of $1.00 per share. The closing of the public offering is expected to occur on or about June 26, 2024, subject to the satisfaction of customary closing conditions. The gross proceeds of the offering are anticipated to be approximately $1,100,000 million before deducting placement agent fees and other estimated offering expenses payable by the Company. The Company intends to use the net proceeds from the offering to fund the continued development...